Figure 5:

Quantification of total (A, i-v) chondroitin sulphate (CS, and its constituents: 0S, 4S and 6S) and (B, i-iii) total HA using FACE (B, i) and commercially available (ELISA-like) Purple Jelley Assay (B, ii) of P21 day old male mice. Neither total lung HA or any CS were affected by CPAP using either FACE analysis of whole lung homogenates (A, i-iv) or by ELISA-like assays (B, i-iii). Representative gels are also provided (A, iv and B, ii). (n=10–12/group).